PTC Therapeutics Provides a Corporate Update and Reports Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 62.82 +0.20 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.62 | 52 Week High | $35.40 | |||
| Open | $62.62 | 52 Week Low | $4.03 | |||
| Day High | $63.04 | P/E | 6.68 | |||
| Day Low | $62.24 | EPS | $9.40 | |||
| Volume | 12,014 | |||||
